ISB News

WRF Gifts $2M to ISB to Advance P4 Medicine

PRESS RELEASE from Washington Research Foundation:

Sept. 30, 2015, Seattle –– Washington Research Foundation (WRF), which supports groundbreaking technology in the life sciences, physical sciences and information sciences in Washington State, announced today that it will provide the Institute for Systems Biology (ISB) with $2 million in funding to bring increased research power to Seattle, and help place this community at the center of the coming transformation of the health care system. The funding will help accelerate ISB’s P4 biomedical research, which is catalyzing a new industry – scientific wellness – and establish Seattle as its epicenter. P4 medicine is predictive, preventive, personalized and participatory and has two central thrusts – quantifying wellness and demystifying disease. The current healthcare industry focuses 98 percent of its efforts and resources on addressing disease. In contrast, P4 medicine will enable the quantification of wellness and promises a revolution in the healthcare system – from a focus on disease to a focus on wellness. This has the potential to save the healthcare systems billions of dollars.

Read full press release…

Recent Articles

  • Dr. Sean Gibbons Promoted to Associate Professor

    Dr. Sean Gibbons – an expert in microbial ecology and evolution, computational systems biology, the human gut microbiome and its impacts on health, and head of ISB’s Gibbons Lab – has been promoted to Associate Professor. “Sean’s achievements since joining ISB in 2018 as a Washington Research Foundation Distinguished Investigator have been spectacular,” ISB President Dr. Jim Heath said. “With his focus on the microbiome, he brought a whole new…

  • AmeriCorps Member Sara Calder Joins ISB as Systems Health and STEM Coordinator

    Sara Calder recently joined ISB as Systems Health and STEM Coordinator, and is our second-ever AmeriCorps member. In this Q&A, Calder shares her education journey, her future plans, and much more.

  • In First-of-Its-Kind Trial, Scientists Use CRISPR to Treat Cancer

    Scientists for the first time have used CRISPR to substitute a gene to treat patients with cancer. The remarkable findings were published in the journal Nature and presented at the Society for Immunotherapy of Cancer (SITC) 2022.